SIRT1 adenoviral vector
SIRT1 adenoviral vector has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 30, 2024: “Deacetylation of HnRNP U mediated by sirtuin1 ameliorates aged rat with liver fibrosis via inhibiting p53-related senescence and NLRP3-related inflammation”.
1 paper studies it3 findingsUpdated
See all 1 papers on SIRT1 adenoviral vector
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals1
What did studies of SIRT1 adenoviral vector find?
3Studies of SIRT1 adenoviral vector measured 3 outcomes: HnRNP U acetylation, p53–p21 pathway and inflammation.
HnRNP U acetylation
downin rat cells1
1 study
HnRNP U acetylation
downin rat cells1
SIRT1 adenoviral vector decreases HnRNP U acetylation in H2O2-induced senescent hepatocytes.
“overexpressing SIRT1 with adenoviral vectors and resveratrol deacetylate HnRNP U”
Cellsin H2O2-induced senescent hepatocytesGFP-SIRT1 adenoviral vectorhepatocyte
International immunopharmacology
p53–p21 pathway
downin rats1
1 study
p53–p21 pathway
downin rats1
SIRT1 adenoviral vector decreases p53–p21 pathway in CCl4-induced liver fibrosis.
“In comparison, these effects were reversed by overexpressing SIRT1 with adenoviral vectors.”
Animalsin CCl4-induced liver fibrosisGFP-SIRT1 adenoviral vectorliver
International immunopharmacology
Inflammation
downin rats1
1 study
Inflammation
downin rats1
SIRT1 adenoviral vector decreases inflammation in CCl4-induced liver fibrosis.
“In comparison, these effects were reversed by overexpressing SIRT1 with adenoviral vectors.”
Animalsin CCl4-induced liver fibrosisGFP-SIRT1 adenoviral vectorliver
International immunopharmacology